Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, NSW, Australia.
St. Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
Cancer Imaging. 2024 Nov 18;24(1):156. doi: 10.1186/s40644-024-00794-5.
There is an unmet need for a more accurate molecular imaging radiotracer in the field of non-seminomatous germ cell tumors (NSGCT). The clinical problem is that no single imaging modality is able to differentiate teratoma from necrotic tissue in NSGCTs, which the nuclear medicine techniques are no exception. The exponential growth in the list of potentially promising radiotracers may hold promise in the future for imaging of NSGCTs. Here, we have reviewed the past efforts and potential future advances in this field.
在非精原细胞瘤生殖细胞肿瘤(NSGCT)领域,存在对更准确的分子成像示踪剂的未满足需求。临床问题是,没有单一的成像方式能够区分 NSGCT 中的畸胎瘤与坏死组织,核医学技术也不例外。潜在有前途的放射性示踪剂的数量不断增加,这可能为 NSGCT 的成像带来希望。在这里,我们回顾了该领域过去的努力和未来的潜在进展。